Plaque Rupture Complications in Murine Atherosclerotic Vein Grafts Can Be Prevented by TIMP-1 Overexpression

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  de Vries, Margreet R ^a   Niessen, Hans W M ^b   Löwik, Clemens W G M ^a   Hamming, Jaap F ^a   Jukema, J Wouter ^a   Quax, Paul H A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE IMAGING; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; VEIN GRAFT; VEIN RUPTURE; VEIN THROMBOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; INCIDENCE; MALE; MICE; MICE, INBRED STRAINS; PLAQUE, ATHEROSCLEROTIC; RUPTURE, SPONTANEOUS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VEINS;

EID: 84867423643     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047134     Document Type: Article

References (41)

1. Virmani R, Burke AP, Kolodgie FD, Farb A, (2002) Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 15: 439-446.
2. Hansson GK, Robertson AK, Soderberg-Naucler C, (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1: 297-329.
3. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, et al. (2003) Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349: 2316-2325.
4. van Lammeren GW, Pasterkamp G, de Vries JP, Bosch L, de Haan JJ, et al. (2012) Platelets enter atherosclerotic plaque via intraplaque microvascular leakage and intraplaque hemorrhage: A histopathological study in carotid plaques. Atherosclerosis 222: 355-359.
5. Shah PK, (1998) Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med 3: 199-206.
6. Galis ZS, Sukhova GK, Lark MW, Libby P, (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503.
7. Nagase H, Visse R, Murphy G, (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573.
8. Bot I, de Jager SC, Bot M, van Heiningen SH, de Groot P, et al. (2010) The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis. Circ Res 106: 89-92.
9. Jackson CL, Bennett MR, Biessen EA, Johnson JL, Krams R, (2007) Assessment of unstable atherosclerosis in mice. Arterioscler Thromb Vasc Biol 27: 714-720.
10. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, et al. (1998) Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 153: 1301-1310.
11. Dietrich H, Hu Y, Zou Y, Huemer U, Metzler B, Li C, et al. (2000) Rapid development of vein graft atheroma in ApoE-deficient mice. Am J Pathol 157: 659-669.
12. Lardenoye JH, de Vries MR, Lowik CW, Xu Q, Dhore CR, et al. (2002) Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice. Circ Res 91: 577-584.
13. Motwani JG, Topol EJ, (1998) Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97: 916-931.
14. Owens CD, (2010) Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg 51: 736-746.
15. Eefting D, de Vries MR, Grimbergen JM, Karper JC, van Bockel JH, et al. (2010) In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. J Vasc Surg 51: 429-437.
16. van der Laan WH, Quax PH, Seemayer CA, Huisman LG, Pieterman EJ, et al. (2003) Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. Gene Ther 10: 234-242.
17. Ewing MM, de Vries MR, Nordzell M, Pettersson K, de Boer HC, et al. (2011) Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice. Arterioscler Thromb Vasc Biol 31: 95-101.
18. Karper JC, de Vries MR, van den Brand BT, Hoefer IE, Fischer JW, et al. (2011) Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice. Arterioscler Thromb Vasc Biol 31: 1033-1040.
19. Kaijzel EL, van Heijningen PM, Wielopolski PA, Vermeij M, Koning GA, et al. (2010) Multimodality imaging reveals a gradual increase in matrix metalloproteinase activity at aneurysmal lesions in live fibulin-4 mice. Circ Cardiovasc Imaging 3: 567-577.
20. Cecchi E, Giglioli C, Valente S, Lazzeri C, Gensini GF, et al. (2011) Role of hemodynamic shear stress in cardiovascular disease. Atherosclerosis 214: 249-256.
21. van Hinsbergh VW, Engelse MA, Quax PH, (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26: 716-728.
22. Sluimer JC, Kolodgie FD, Bijnens AP, Maxfield K, Pacheco E, et al. (2009) Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 53: 1517-1527.
23. Jackson CL, (2007) Defining and defending murine models of plaque rupture. Arterioscler Thromb Vasc Biol 27: 973-977.
24. Falk E, Schwartz SM, Galis ZS, Rosenfeld ME, (2007) Putative murine models of plaque rupture. Arterioscler Thromb Vasc Biol 27: 969-972.
25. Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS, (1999) Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost 81: 177-188.
26. Bouma BN, Meijers JC, (2003) Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). J Thromb Haemost 1: 1566-1574.
27. Zhu Y, Carmeliet P, Fay WP, (1999) Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 99: 3050-3055.
28. Virmani R, Burke AP, Farb A, Kolodgie FD, (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47: C13-C18.
29. Motwani JG, Topol EJ, (1998) Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97: 916-931.
30. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, et al. (1996) Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 93: 1354-1363.
31. Deguchi JO, Aikawa E, Libby P, Vachon JR, Inada M, et al. (2005) Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 112: 2708-2715.
32. Eefting D, Seghers L, Grimbergen JM, de Vries MR, de Boer HC, et al. (2010) A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease. Cardiovasc Res 88: 367-375.
33. Gough PJ, Gomez IG, Wille PT, Raines EW, (2006) Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 116: 59-69.
34. Hu Y, Baker AH, Zou Y, Newby AC, Xu Q, (2001) Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model. Arterioscler Thromb Vasc Biol 21: 1275-1280.
35. Johnson JL, George SJ, Newby AC, Jackson CL, (2005) Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci U S A 102: 15575-15580.
36. Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, et al. (2004) Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 109: 1408-1414.
37. Thomas AC, Newby AC, (2010) Effect of matrix metalloproteinase-9 knockout on vein graft remodelling in mice. J Vasc Res 47: 299-308.
38. Rouis M, Adamy C, Duverger N, Lesnik P, Horellou P, et al. (1999) Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation 100: 533-540.
39. Johnson JL, Baker AH, Oka K, Chan L, Newby AC, et al. (2006) Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation 113: 2435-2444.
40. Lardenoye JH, de Vries MR, Deckers M, van Lent N, Hanemaaijer R, et al. (2005) Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo. EuroIntervention 1: 236-243.
41. Schneider F, Sukhova GK, Aikawa M, Canner J, Gerdes N, et al. (2008) Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques. Circulation 117: 931-939.